Cytomegalovirus disease occurring before engraftment in marrow transplant recipients

Clinical Infectious Diseases

Volumn 24, Issue 5, 1997, Pages 830-835

  Limaye, Ajit P ^b   Bowden, Raleigh A ^b   Myerson, David ^b   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTOMEGALOVIRUS ANTIBODY; FOSCARNET; GANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HERPES; HERPES SIMPLEX VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME; VIRUS PNEUMONIA;

EID: 0030901675     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.5.830     Document Type: Article

References (20)

1. Meyers JD, Floumoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 1982;4:1119-32.
2. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
3. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993;118:173-8.
4. Winston DJ, Ho WG, Bartoni K, et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled double-blind trial. Ann Intern Med 1993;118:179-84.
5. Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601-7.
6. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-20.
7. Enright H, Haake R, Weisdorf D, et al. Cytomegalovirus pneumonia after bone marrow transplantation. Transplantation 1993;55:1339-46.
8. Boeckh M, Bowden RA. Cytomegalovirus infection in marrow transplantation. In: Buckner CD, Clift RA, eds. Technical and biological components of marrow transplantation. Boston: Kluwer Academic Publishers, 1995.
9. Nagler A, Elishoov H, Kapelushnik Y, Breuer R, Or R, Engelhard D. Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation. Medical Oncol 1995;11:127-32.
10. Ljungman P, Engelhard D, Link H, et al. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European bone marrow transplant group. Clin Infect Dis 1992:14:831-5.
11. Boeckh M, Gleaves CA, Bindra R, Meyers JD. Comparison of MRC-5 and U-373MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures. Eur J Clin Microbiol Infect Dis 1991;10:569-72.
12. Boeckh M, Myerson D, Bowden RA. Early detection and treatment of cytomegalovirus infections in marrow transplant patients: methodological aspects and implications for therapeutic interventions. Bone Marrow Transplant 1994;14(suppl 4):S66-70.
13. Meyers JD, Reed EC, Shepp DH, et al. Acyclovir for the prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988;318:70-5.
14. Boeckh M, Gooley TA, Reusser P, Buckner CD, Bowden RA. Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation. J Infect Dis 1995;172:939-43.
15. Meyers JD, Floumoy N, Thomas ED. Risk factors for the cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153:478-88.
16. Brytting M, Mousavijazi M, Bostrom L, et al. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Transplantation 1995;60:961-5.
17. Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993;56:330-4.
18. Aspin MM, Gallez-Hawkins CM, Giugni TD, et al. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 1994;32:2266-9.
19. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988;109:783-8.
20. Schmidt GM, Kavacs A, Zaia JA, et al. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988;46:905-7.